Mesa Laboratories, Inc.
MLAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $60,737 | $59,543 | $62,135 | $62,840 |
| % Growth | 2% | -4.2% | -1.1% | – |
| Cost of Goods Sold | $23,406 | $27,049 | $23,723 | $23,086 |
| Gross Profit | $37,331 | $32,494 | $38,412 | $39,754 |
| % Margin | 61.5% | 54.6% | 61.8% | 63.3% |
| R&D Expenses | $5,048 | $4,984 | $5,096 | $5,053 |
| G&A Expenses | $17,763 | $17,958 | $20,579 | $18,472 |
| SG&A Expenses | $27,559 | $28,891 | $31,847 | $28,922 |
| Sales & Mktg Exp. | $9,796 | $10,933 | $11,268 | $10,450 |
| Other Operating Expenses | $0 | -$4,445 | $0 | $0 |
| Operating Expenses | $32,607 | $29,430 | $36,943 | $33,975 |
| Operating Income | $4,724 | $3,064 | $1,469 | $5,779 |
| % Margin | 7.8% | 5.1% | 2.4% | 9.2% |
| Other Income/Exp. Net | -$2,725 | $3,948 | -$1,008 | -$7,996 |
| Pre-Tax Income | $1,999 | $7,012 | $461 | -$2,217 |
| Tax Expense | -$477 | $2,270 | $7,575 | -$541 |
| Net Income | $2,476 | $4,742 | -$7,114 | -$1,676 |
| % Margin | 4.1% | 8% | -11.4% | -2.7% |
| EPS | 0.45 | 0.87 | -1.31 | -0.31 |
| % Growth | -48.3% | 166.4% | -322.6% | – |
| EPS Diluted | 0.45 | 0.85 | -1.31 | -0.31 |
| Weighted Avg Shares Out | 5,512 | 5,465 | 5,429 | 5,429 |
| Weighted Avg Shares Out Dil | 5,535 | 5,553 | 5,429 | 5,429 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,862 | $2,198 | $2,519 | $2,842 |
| Depreciation & Amortization | $5,849 | $5,957 | $7,497 | $5,497 |
| EBITDA | $10,710 | $15,167 | $10,477 | $6,122 |
| % Margin | 17.6% | 25.5% | 16.9% | 9.7% |